Acasti pharma announces annual grants of performance stock options

Laval, quÉbec, june 22, 2022 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), a late-stage, specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases, today announced the annual grant of performance stock options to its employees and executives.
ACST Ratings Summary
ACST Quant Ranking